Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
9.29
-0.11 (-1.17%)
Apr 16, 2026, 10:18 AM EDT - Market open
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $561.63 million as of April 16, 2026. Its market cap has increased by 573.38% in one year.
Market Cap
561.63M
Enterprise Value
312.01M
1-Year Change
573.38%
Ranking
Category
Stock Price
$9.29
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $561.63M, a decrease of -37.46%. That is a compound annual growth rate of -19.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 568.28M | 5.82% |
| Dec 31, 2025 | 537.02M | 232.60% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocugen | 604.84M |
| Crescent Biopharma | 597.52M |
| ProKidney | 588.74M |
| MiMedx Group | 582.38M |
| CorMedix | 578.65M |
| Lyell Immunopharma | 578.54M |
| Zevra Therapeutics | 570.68M |
| Tectonic Therapeutic | 562.55M |